Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2998695 | 1.00 | L3MBTL1 (0.70) | L3MBTL1ALDH1A1GAAGFERMAOA | |
| SCHEMBL2998723 | 0.98 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1GAAGFERMAOA | |
| SCHEMBL6639389 | 0.84 | RAB9A (0.61) | L3MBTL1ALDH1A1GAAPTGS2EPHX1 | |
| SCHEMBL8387722 | 0.83 | DEGS1 (0.53) | L3MBTL1ALDH1A1GAAGFEREPHX1 | |
| SCHEMBL11623816 | 0.83 | L3MBTL1 (0.74) | L3MBTL1ALDH1A1GAAGFERMAOA | |
| SCHEMBL8180075 | 0.82 | NPC1 (0.60) | L3MBTL1PTGS2SMN1; SMN2CA1CA9 | |
| SCHEMBL27470376 | 0.81 | ALDH1A1 (0.60) | L3MBTL1ALDH1A1GAAMAOAMAOB | |
| SCHEMBL30516201 | 0.77 | METAP2 (0.52) | GAATP53SMN1; SMN2HPGDLMNA | |
| SCHEMBL23861294 | 0.76 | RAB9A (0.52) | L3MBTL1ALDH1A1GAASMN1; SMN2LMNA | |
| SCHEMBL2992964 | 0.75 | ALDH1A1 (1.00) | L3MBTL1ALDH1A1GAAMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100184811-A1 | ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS | BRIDGE BIORESEARCH RIGHTS (JERSEY) LIMITED (GB) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184811-A1 | ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS | ODC1, OTC, ACACB | L3MBTL1 1229/4885ALDH1A1 302/4885GAA 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.